{
    "id": 20902,
    "cites": 66,
    "cited_by": 23,
    "reference": [
        "Aghion P, Bloom N, Blundell RW, Gri th R, Howitt P. 2005. Competition and innovation: An inverted-U relationship. Quarterly Journal of Economics 120(2): 701\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 28.",
        "Argyres NS, Silverman BS. 2004. R&D, organization structure, and the development of corporate technological knowledge. Strategic Management Journal 25(89): 929\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 958.",
        "Arora A, Belenzon S, Rios LA. 2014. Make, buy, organize: The interplay between research, external knowledge, and \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rm structure. Strategic Management Journal 35(3): 317\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 337.",
        "Arora A, Fosfuri A, Gambardella A. 2001. Markets for technology: economics of innovation and corporate strategy. MIT Press: Cambridge, MA.",
        "Arora A, Gambardella A. 1990. Complementarity and external linkages: the strategies of the large \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rms in biotechnology. Journal of Industrial Economics 38(4): 361\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 379.",
        "Arora A, Gambardella A. 1994. The changing technology of technological change: general and abstract knowledge and the division of innovative labour. Research Policy 23(5): 523\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 532.",
        "Arrow K. 1962. Economic welfare and the allocation of resources of inventions. In The rate and direction of inventive activity. Princeton University Press: Princeton, NJ.",
        "Audretsch DB, Stephan PE. 1996. Company-scientist locational links: the case of biotechnology. American Economic Review 86(3): 641\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 652.",
        "Azoulay P. 2002. Do pharmaceutical sales respond to scienti\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6c evidence? Journal of Economics & Management Strategy 11(4): 551\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 594.",
        "Azoulay P. 2004. Capturing knowledge within and across \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rm boundaries: evidence from clinical development. American Economic Review 94(5): 1591\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 1612.",
        "Bloom N, Draca M, Van Reenen J. 2011. Trade induced technical change? The impact of Chinese imports on innovation, IT and productivity. NBER Working Paper No. w16717.",
        "Bhaskarabhatla A, Hegde D. 2014. An organizational perspective on patenting and open innovation. Organization Science 25(6): 1744\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 1763.",
        "Block F, Keller MR. 2009. Where do innovations come from? Transformations in the US economy, 1970\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 2006. Socio-Economic Review 7(3): 459\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 483.",
        "Carlson BW. 2013. Innovation and the modern corporation. From heroic invention to industrial science. In Krige J, Pestre D (Eds.), Companion Encyclopedia of Science in the Twentieth Century. Routledge: New York, NY.",
        "Christensen CM, Bower JL. 1996. Customer power, strategic investment and the failure of leading \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rms. Strategic Management Journal 17: 197\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 218.",
        "Cockburn IM, Henderson RM. 1998. Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery. Journal of Industrial Economics 46(2): 157\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 182.",
        "Cohen WM. 2010. Fifty years of empirical studies of innovative activity and performance. In Hall BH, Rosenberg N (Eds.), Handbook of the economics of innovation. Amsterdam: NorthHolland.",
        "Cohen WM, Levinthal DA. 1989. Innovation and learning: the two faces of R & D. Economic Journal 99(397): 569\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 596.",
        "Deng Z, Lev B, Narin F. 1999. Science and technology as predictors of stock performance. Financial Analysts Journal 55: 20\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 32.",
        "The rise and fall of corporate R&D. 2007. The Economist. March 1st.",
        "Evenson RE, Kislev Y. 1976. A stochastic model of applied research. Journal of Political Economy 84(2): 265-281.",
        "Fabrizio KR, Di Minin AD. 2008. Commercializing the laboratory: Faculty patenting and the open science environment. Research Policy 37(5): 914\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 931.",
        "Fleming L, Sorenson O. 2004. Science as a map in technological search. Strategic Management Journal 25(8-9): 909\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 928.",
        "Gambardella A. 1992. Competitive advantages from in-house scienti\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6c research: The US pharmaceutical industry in the 1980s. Research policy 21(5): 391\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 407.",
        "Gambardella A. 1995. Science and innovation: The US pharmaceutical industry during the 1980s. Cambridge University Press: Cambridge, MA.",
        "Gans JS, Murray FE, Stern S. 2013. Contracting over the disclosure of scienti\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6c knowledge: Intellectual property and academic publication. NBER Working Paper No. 19560.",
        "Griliches Z. 1986. Productivity, R&D, and basic research at the \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rm level in the 1970s. American Economic Review 76(1): 141\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 154.",
        "Guellec D, van Pottelsberghe de la Potterie B. 2007. The economics of the European patent system. IP Policy for Innovation and Competition, Oxford University Press, New York.",
        "Hall BH, Jae A, Trajtenberg M. 2005. Market value and patent citations. Rand Journal of Economics 36(1): 16\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 38.",
        "Henderson R, Cockburn IM. 1996. Scale, scope, and spillovers: the determinants of research productivity in drug discovery. Rand journal of economics. 32-59",
        "Hicks D. 1995. Published papers, tacit competencies and corporate management of the public /private character of knowledge. Industrial and Corporate Change 4: 401\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 424.",
        "Higgins MJ, Rodriguez D. 2006. The outsourcing of R&D through acquisitions in the pharmaceutical industry. Journal of Financial Economics 80(2): 351\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 383.",
        "Hounshell DA, Smith JK Jr. 1986. Science and corporate strategy: DuPont R&D, 1902\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 1980. Cambridge University Press: New York.",
        "Jae AB, Lerner J. 2004. Innovation and its discontents: how our broken patent system is endangering innovation and progress, and what to do about it. Princeton University Press.",
        "Jones BF. 2009. The burden of knowledge and the death of the Renaissance man. Review of Economic Studies 76(1): 283-317.",
        "Kay N. 1988. The R&D function: corporate strategy and structure. In G. Dosi, C. Freeman, R. Nelson, G. Silverberg, and C. Soete (Eds.), Technical Change and Economic Theory. Pinter: London, UK; 282\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 294.",
        "Kelchtermans S, Leten B, Belderbos R. 2011. When does in-house basic research increase \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rms\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 technological performance? K.U.Leuven\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d Faculty of Business and Economics working paper.",
        "Koenig MED. 1983. A bibliometric analysis of pharmaceutical research. Research Policy 12(1): 15\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 36.",
        "Kortum S, Lerner J. 2000. Assessing the contribution of venture capital to innovation. Rand Journal of Economics 31: 674\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 692.",
        "Lazonick W. 2013. The \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6nancialization of the U.S. corporation: What has been lost, and how it can be regained. Seattle University Law Revew 36: 857\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 909.",
        "Lazonick W, Tulum O, 2011. US biopharmaceutical \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6nance and the sustainability of the biotech business model. Research Policy 40(9): 1170\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 1187.",
        "Lerner J. 1999. The government as venture capitalist: the long-run eects of the SBIR program. Journal of Business 72: 285\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 318.",
        "Leten B, Kelchtermans S, Belderbos R. 2010. Internal basic research, external basic research and the technological performance of pharmaceutical \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rms. K.U.Leuven\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d Faculty of Business and Economics working paper.",
        "Lichtenberg FR. 1988. The private R&D investment response to Federal design and technical competitions. American Economic Review 78: 550\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 559.",
        "Link AN, Long JE. 1981. The simple economics of basic scienti\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6c research: A test of Nelson\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2 s diversi\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6cation hypothesis. Journal of Industrial Economics 30(1): 105\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 109.",
        "Mazzucato M. 2013. The entrepreneurial state. Debunking public vs. private sector myths. Anthem Press: London, UK.",
        "Meoli M, Paleari S, Vismara S. 2013. Completing the technology transfer process: M&As of science-based IPOs. Small Business Economics 40(2): 227\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 248.",
        "Mokyr, Joel. 2002. The gifts of Athena: Historical origins of the knowledge economy. Princeton University Press.",
        "Mowery DC. 1995. The boundaries of the U.S. \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rm in R&D. In NR. Lamoreaux and DMG. Ra (Eds.), Coordination and Information: Historical Perspectives on the Organization of Enterprise. University of Chicago Press: Chicago, 147\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 182.",
        "Mowery DC. 2009. Plus ca change: industrial R&D in the \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093third industrial revolution\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d . Industrial and Corporate Change 18(1): 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 50.",
        "Murray F. 2002. Innovation as co-evolution of scienti\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6c and technological networks: Exploring tissue engineering. Research Policy 31(8\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 9): 1389\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 1403.",
        "Murray F. 2004. The role of academic inventors in entrepreneurial \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rms: Sharing the laboratory life. Research Policy 33(4): 643\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 659.",
        "Narin F, Hamilton KS, Olivastro D. 1997. The increasing linkage between U.S. technology and public science. Research Policy 26(3): 317\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 330.",
        "Nelson RR. 1959. The simple economics of basic scienti\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6c research. Journal of Political Economy 67(3): 297\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 306.",
        "Patacconi A, Swierzbinski J, Williams J. 2012. Knowledge protection in \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rms: theory and evidence from HP Labs. Working paper.",
        "Pisano G. 2006. Science business: The promise, the reality, and the future of biotech. Harvard Business School Press: Cambridge, MA.",
        "Pisano G. 2010. The evolution of science-based business: innovating how we innovate. Industrial and Corporate Change 19(2): 465\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 482.",
        "Roach M, Sauermann H. 2010. A taste for science? PhD scientists\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2academic orientation and self-selection into research careers in industry. Research Policy 39(3): 422\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 434.",
        "Rosenberg N. 1990. Why do \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rms do basic research (with their own money)? Research Policy 19(2): 165\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 174.",
        "Schumpeter JA. 1942. Capitalism, socialism and democracy. New York: Harper & Brothers.",
        "Simeth M, Cincera M. 2013. Corporate science, innovation, and \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rm value. K.U.Leuven\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d Faculty of Business and Economics working paper.",
        "Stern S. 2004. Do scientists pay to be scientists? Management Science 50(6): 835\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 853.",
        "Sull DN, Tedlow RS, Rosenbloom RS. 1997. Managerial commitments and technological change in the US tire industry. Industrial and Corporate Change 6(2): 461\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 500.",
        "Teece DJ. 2010. Technological innovation and the theory of the \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u00a6rm: the role of enterpriselevel knowledge, complementarities, and (dynamic) capabilities. In BH. Hall and N. Rosenberg (Eds.), Handbook of the Economics of Innovation (Vol. 1), 679\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 730.",
        "Valentini, G. 2012. Measuring the eect of M&A on patenting quantity and quality. Strategic Management Journal 33(3): 336\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 346.",
        "Van Looy B, Zimmermann E, Veugelers R, Verbeek A, Mello J, Debackere K. 2003. Do sciencetechnology interactions pay o when developing technology? Scientometrics 57(3): 355\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 367. VARIABLES No. Obs. Mean Std. Dev. 10th 50th 90th Panel A: Compustat firms Market value ($, mm) 11,304 5,920 20,278 33 677 12,208 Assets t-1 ($, mm) 11,304 3,017 9,681 24 397 7,328 Sales t-1 ($, mm) 11,304 3,410 9,805 35 677 12,208 Publication stock 11,304 58 389 0 0 20 Publication flow 11,304 10 58 0 0 8 Patent stock 11,304 174 664 2 19 314 Patent flow 11,304 26 101 0 2 46 Panel B: Acquisition target firms (SDC Platinum) Target value ($, mm) 26,884 155 251 6 57 424 Net assets ($, mm) 26,884 75 116 2 30 209 Sales ($, mm) 26,884 133 51 4 51 400 Publication stock 836 3 13 0 0.2 6 Patent stock 3,767 31 73 0 4 87 TABLE 1. SUMMARY STATISTICS FOR MAIN VARIABLES Distribution"
    ]
}